Corning just printed Q2 results, dropped another 12% in a single session, and now trades 43% below where it was a month ago — yet every analyst who updated their model this morning kept a positive or neutral rating and pointed to targets still well above the current price.
The Street's reaction to results is the defining story this week. Five firms moved their targets lower on July 29 alone, but the direction of those cuts is telling. Citigroup lowered to $220 from $240 while keeping its Buy. Mizuho dropped to $210 from $270, still Outperform. Oppenheimer trimmed to $200 from $230, maintaining Outperform. JP Morgan's Samik Chatterjee cut to $170 from $200 at Neutral, and Barclays moved to $129 — the lone voice near current levels — from $180 at Equal-Weight. The consensus mean now sits at $193, implying roughly 53% upside from the $126 close. That is a historically wide gap, and it reflects a Street that believes the sell-off has overshot the earnings reality rather than one abandoning the thesis. The bulls cite Corning's exposure to AI-driven optical fibre demand and partnerships with hyperscalers including Meta and Amazon. The bear case centres on the stock's stretched forward multiples — the P/E has compressed sharply but still runs near 33x trailing earnings — and the risk that AI capex spending moderates.
Short positioning tells a notably calm story relative to the scale of the price move. Short interest has been falling through the rout, down more than 11% over the past month to just 2.1% of the free float. Borrow is extraordinarily loose: availability is running at more than 8,000% — meaning for every share currently lent out, there are roughly 80 available to borrow — and the cost to borrow remains negligible at 0.57%. Shorts did not drive this decline. The positioning data is consistent with holders selling, not new short sellers pressing a thesis. The ORTEX short score has also been drifting lower, from 31.3 earlier in the month to 30.2 now, reinforcing the picture of a stock that bears are not rushing to press even after a 43% drawdown.
Options positioning, however, has shifted into territory worth monitoring. The put/call ratio is running at 1.07, above its 52-week high of 1.09 reached yesterday, and more than one standard deviation above its 20-day average of 0.96. Defensive hedging demand has been elevated for two weeks — as noted in prior coverage, the PCR was already elevated before the Q2 print — and it has held there through results. That does not suggest imminent relief. It suggests holders are still buying protection rather than adding exposure.
The insider picture adds a complicating layer. Over the 90 days ending June 22, executives collectively sold roughly $96.7 million worth of stock — and that was at prices ranging from $186 to $210, well above where the stock trades now. CEO Wendell Weeks sold 100,000 shares at an average of $186 in early June. The CTO, COO, and several senior VPs also reduced exposure through May and June. None of these trades were unusual in isolation, and they predate the sharper leg of the decline, but the cluster of executive selling at now-elevated historical prices is a data point institutional holders will consider as they assess whether the remaining gap between price and consensus target is an opportunity or a warning.
Closest correlated peer COHR fell 10% on the day and 23% on the week — mirroring Corning's move almost exactly. FLEX and ROG each lost 11-13% on the week, suggesting the sector is under broad pressure beyond any Corning-specific story. The key variable to track from here is whether institutional buyers — BlackRock and Capital Research both added positions as recently as June 30 — begin to deploy capital at current levels, or whether the analyst target cluster around $170-$220 simply drifts lower as model revisions continue into Q3.
See the live data behind this article on ORTEX.
Open GLW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.